Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome

Publié dans Thrombosis and Haemostasis. 2016 Jan; 115(2):382-389 Auteurs : Collet JP, Kerneis M, Hulot JS, O'Connor SA, Silvain J, Mansencal N, Brugier D, Abtan J, Barthélémy O, Vignalou JB, Payot L, Rousseau H, Vicaut E, Montalescot G; GAMMA Investigators. Article disponible en consultant le site Abstract Abstract : Our aim was to demonstrate that…

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Publié dans American Heart Journal. 2015 Dec; 170(6):1061-1069 Auteurs : Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KA, Gibson CM, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G, Weerakkody GJ, Nissen SE. Article disponible en consultant le site Abstract Background and aim :…

Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction : From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study

Publié dans American Heart Journal. 2015 Nov; 170(5):1025-1032 Auteurs : Dudek D, Dziewierz A, Widimsky P, Bolognese L, Goldstein P, Hamm C, Tanguay JF, LeNarz L, Miller DL, Brown E, Ten Berg J, Montalescot G; ACCOAST Investigators. Article disponible en consultant le site Abstract Objectives : We evaluated impact of timing of coronary artery bypass…